Skip to main content
. Author manuscript; available in PMC: 2020 Dec 1.
Published in final edited form as: Hypertension. 2019 Nov 4;74(6):1373–1382. doi: 10.1161/HYPERTENSIONAHA.119.13496

Table 3:

Associations of PWV measures, derived CAVI, and derived CFVI with the risk of all-cause mortality

Characteristics Q1 Q2 Q3 Q4

HR (95% CI) P* HR (95% CI) P* HR (95% CI) P*
Central arterial stiffness
cfPWV Model 1 1.01 (0.65, 1.57) 0.96 ref 1.76 (1.19, 2.62) 0.01 1.55 (1.04, 2.32) 0.03
Model 2 1.11 (0.71, 1.73) 0.65 ref 1.60 (1.08, 2.39) 0.02 1.24 (0.82, 1.87) 0.30
Model 3 1.13 (0.72, 1.76) 0.59 ref 1.55 (1.04, 2.32) 0.03 1.13 (0.74, 1.72) 0.57
Model 4 1.07 (0.69, 1.68) 0.75 ref 1.44 (0.96, 2.15) 0.07 0.99 (0.65, 1.51) 0.96

hfPWV Model 1 1.08 (0.71, 1.66) 0.71 ref 1.39 (0.92, 2.09) 0.11 1.71 (1.15, 2.53) 0.01
Model 2 1.21 (0.79, 1.86) 0.39 ref 1.26 (0.84, 1.90) 0.27 1.38 (0.92, 2.06) 0.12
Model 3 1.28 (0.83, 1.96) 0.27 ref 1.21 (0.80, 1.82) 0.37 1.21 (0.80, 1.83) 0.37
Model 4 1.25 (0.81, 1.93) 0.31 ref 1.19 (0.79, 1.80) 0.40 1.02 (0.67, 1.55) 0.94

Derived CFVI Model 1 1.24 (0.80, 1.93) 0.33 ref 1.51 (0.99, 2.30) 0.06 2.03 (1.36, 3.03) 0.001
Model 2 1.31 (0.85, 2.04) 0.22 ref 1.30 (0.85, 2.00) 0.22 1.56 (1.03, 2.36) 0.04
Model 3 1.42 (0.92, 2.21) 0.12 ref 1.26 (0.82, 1.93) 0.29 1.40 (0.92, 2.14) 0.11
Model 4 1.40 (0.90, 2.18) 0.13 ref 1.24 (0.81, 1.90) 0.32 1.23 (0.81, 1.89) 0.33

Composite arterial stiffness
baPWV Model 1 0.92 (0.62, 1.37) 0.69 ref 1.08 (0.73, 1.59) 0.69 1.65 (1.16, 2.35) 0.01
Model 2 1.06 (0.71, 1.59) 0.76 ref 0.99 (0.67, 1.45) 0.95 1.33 (0.93, 1.90) 0.12
Model 3 1.06 (0.70, 1.59) 0.78 ref 0.98 (0.66, 1.45) 0.91 1.27 (0.87, 1.85) 0.21
Model 4 1.02 (0.68, 1.54) 0.92 ref 0.99 (0.67, 1.46) 0.95 1.28 (0.88, 1.86) 0.21

haPWV Model 1 1.06 (0.70, 1.60) 0.79 ref 1.02 (0.67, 1.55) 0.93 1.59 (1.08, 2.34) 0.02
Model 2 1.18 (0.78, 1.79) 0.44 ref 0.94 (0.61, 1.43) 0.76 1.25 (0.85, 1.85) 0.26
Model 3 1.26 (0.83, 1.92) 0.29 ref 0.88 (0.58, 1.35) 0.57 1.07 (0.71, 1.61) 0.74
Model 4 1.22 (0.80, 1.86) 0.36 ref 0.87 (0.57, 1.33) 0.51 1.06 (0.70, 1.60) 0.79

Derived CAVI Model 1 1.30 (0.84, 2.03) 0.24 ref 1.63 (1.07, 2.49) 0.02 1.98 (1.32, 2.99) 0.001
Model 2 1.37 (0.88, 2.14) 0.16 ref 1.39 (0.91, 2.13) 0.13 1.42 (0.93, 2.16) 0.11
Model 3 1.54 (0.99, 2.41) 0.06 ref 1.37 (0.89, 2.10) 0.15 1.24 (0.81, 1.91) 0.32
Model 4 1.45 (0.93, 2.27) 0.11 ref 1.34 (0.87, 2.06) 0.18 1.25 (0.81, 1.92) 0.32

Model 1: Crude

Model 2: Age, sex, race

Model 3: Model 2 + education, current smoking, body mass index, history of diabetes, mean arterial pressure, antihypertensive medication, total cholesterol, high-density lipoprotein

Model 4: Model 3 + ankle brachial index, estimated glomerular filtration rate, albumin-creatinine ratio

HR=hazard ratio; Q1, Q2, Q3, Q4=quartile 1, quartile 2, quartile 3, quartile 4

*

P-values test quartile-specific estimates vs. the referent (quartile 2)